: Theft in open court: How a fight over lifesaving drugs led to accusations of brazen industrial espionage

Cancer drug developer I-Mab says a key competitor stole its research by posing as an expert witness in an arbitration proceeding.

Previous post Economic Report: Consumer confidence jumps to 17-month high as inflation slows. Americans more optimistic on economy
Next post Cannabis Watch: Canopy Growth cuts 1,200 jobs in past year and issues ‘going concern’ warning as analyst eyes solvency of cannabis company